United States · FDA National Drug Code directory
Eribulin Mesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81298-3890_68589863-7488-4661-bbbe-9838b7d0396d
- Product NDC
- 81298-3890
- Form
- SOLUTION
- Composition / generic term
- Eribulin Mesylate
- Labeler
- Long Grove Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240722
- Source listing expiry
- 20261231
Source-listed ingredients
- ERIBULIN MESYLATE — .5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (81298-3890-1) / 2 mL in 1 VIAL, SINGLE-DOSE · 81298-3890-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →